Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

I don't think you quite understand the dynamics of the process re: stock price appreciation. Speculation will certainly build even before submission of the MAA, let alone imminent potential approval.

Note also that orphan designation and high unmet needs often will cause the regs to move more quickly. I can't say with certainty how long things will take once they're rolling. But if you're trying to sow an impression of "there's nothing to expect until 2018," then you must be new to this.